Logiscreen

Haemonetics Corp

$119.97
Market Cap 5.45B
ROE 11.3%
Gross Margin 59.8%
Debt/Equity 1.4
Current Ratio 3.1
Revenue QoQ 5.6%
EPS QoQ 0.0%
F-Score 7

About

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies designed to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
36.39
vs median 36.93
P/B
4.45
vs median 2.32
ROE
0.11
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics